Ran Bio-Pharma Private Limited - Company Profile

It is a chemicals private limited company based in Visakhapatnam, Andhra Pradesh, India, established in 2011.
2011 Visakhapatnam, Andhra Pradesh, India Struck Off
Last Updated:
Access Report
About Ran Bio-Pharma Private Limited

Ran Bio-Pharma Private Limited, a struck off private limited company, was established on 30 June 2011 in Visakhapatnam, Andhra Pradesh, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24232AP2011PTC075293. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

Its leadership includes Rongali Atchum Naidu (Director), Tumarada Chandra Mouliswara Rao (Director). Its latest AGM occurred on 31 December 2012, with the balance sheet filed on 31 March 2012. It is based at # 14-37-33B, Beside Vijay Medical Centre Krishna Nagar, Maharanipeta, Visakhapatnam, Andhra Pradesh, 530002.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232AP2011PTC075293

  • Registration Number

    075293

  • Incorporation Date

    30 June 2011

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Vijayawada

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 14 Year, 8 Months
  • Last Filing with ROC 31 Mar 2012
Company report

Ran Bio-Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Ran Bio-Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Ran Bio-Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Rongali Atchum Naidu Director 30 Jun 2011 Current
Tumarada Chandra Mouliswara Rao Director 30 Jun 2011 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Ran Bio-Pharma.

Enhance accessibility to Ran Bio-Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Ran Bio-Pharma revenue growth over time
Ran Bio-Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Ran Bio-Pharma?

Unlock access to Ran Bio-Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Ran Bio-Pharma?

Unlock and access historical data on people associated with Ran Bio-Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Ran Bio-Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ran Bio-Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Ran Bio-Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Ran Bio-Pharma Private Limited last Annual general meeting of members was held on 31 Dec 2012 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Ran Bio-Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2012 with Roc Vijayawada. was documented.

  • Director Appointment

    The activity Rongali Atchum Naidu was appointed as a Director was appointed as a Director on 30 Jun 2011 & has been associated with this company since 14 years 8 months . was completed.

  • Director Appointment

    The activity Tumarada Chandra Mouliswara Rao was appointed as a Director was appointed as a Director on 30 Jun 2011 & has been associated with this company since 14 years 8 months . was completed.

  • Company Incorporation

    The activity Ran Bio-Pharma Private Limited was registered on 30 Jun 2011 with Roc Vijayawada & aged 14 years 8 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Ran Bio-Pharma Private Limited?

The CIN of Ran Bio-Pharma Private Limited is U24232AP2011PTC075293.

Where is Ran Bio-Pharma Private Limited headquartered?

Ran Bio-Pharma Private Limited is headquartered at # 14-37-33B, Beside Vijay Medical Centre Krishna Nagar, Maharanipeta, Visakhapatnam, Andhra Pradesh, 530002.

When was Ran Bio-Pharma Private Limited incorporated?

Ran Bio-Pharma Private Limited was incorporated on 30 June 2011.

Who are the current directors of Ran Bio-Pharma Private Limited?

The current directors of Ran Bio-Pharma Private Limited are

What is the primary industry of Ran Bio-Pharma Private Limited?

The primary industry of Ran Bio-Pharma Private Limited is Chemicals.

Is Ran Bio-Pharma Private Limited a listed company?

Ran Bio-Pharma Private Limited is unlisted.

What is the capital structure of Ran Bio-Pharma Private Limited?

The authorized capital of Ran Bio-Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available